The Adaptive Immune Response

Vocabulary practice flashcards covering adaptive immunity, lymphatic anatomy, B- and T-cell activation, antibody classes and functions, and MHC-mediated self-recognition.

Adaptive Immunity

An acquired immune defense that develops throughout life, 'learning' about microbial invaders and generating long-lasting immunological memory for faster responses upon future re-exposure.

Memory (Adaptive Immunity)

The ability of the adaptive immune system to mount a stronger, more rapid response upon subsequent exposure to a specific antigen, providing long-term protection and serving as the biological basis for vaccination.

Specificity (Adaptive Immunity)

The precision of the adaptive immune response that allows it to target and eliminate pathogenic variants of normally innocuous microbes while sparing host tissues and harmless entities.

Humoral Immunity

The branch of adaptive immunity mediated by B lymphocytes and plasma cell-derived antibodies that functions to remove extracellular antigens such as bacteria, viruses, fungi, and helminths.

Cell-Mediated Immunity

The branch of adaptive immunity driven by T lymphocytes that targets and clears intracellular antigens, such as actively replicating viruses or bacteria concealed inside host cells.

Primary Response

The initial adaptive immune reaction to a novel antigen, requiring a delay of a week or more to build while generating effector cells and immunological memory.

Secondary Response

A subsequent, dramatically faster and more intense immune response to an antigen previously encountered, mediated by an expanded pool of distributed memory cells.

Naive B Cells

A pool of approximately $210\text{ billion}$ unactivated B lymphocytes, each pre-programmed with unique surface B-cell receptors to accommodate an enormous range of potential foreign antigens.

Plasma Cells

Effector descendants of activated B cells that function as specialized antibody-secreting factories packed with extensive rough endoplasmic reticulum; each typically undergoes apoptosis after $2\text{–}3\text{ days}$.

B-Memory Cells

Long-lived, differentiated B lymphocytes that disperse throughout the body's secondary lymphoid tissues to provide rapid antibody production upon antigen re-encounter.

Naive T Cells

A pool of roughly $100\text{ billion}$ unactivated T lymphocytes circulating through the lymphatic and vascular systems, capable of recognizing a vast array of intracellular or presented peptide antigens.

Cytotoxic T Cells ($\text{T}_\text{C}$ / CD8)

Effector hunter-killer lymphocytes that recognize endogenous viral or abnormal peptides presented on MHC Class I molecules and destroy infected 'self' cells by delivering 'death packages' to induce apoptosis.

Helper T Cells ($\text{T}_\text{H}$ / CD4)

Effector lymphocytes that inspect exogenous antigens presented on MHC Class II molecules to confirm immune responses, secrete regulatory cytokines, and activate B cells and macrophages.

Lymph

Colorless interstitial fluid collected from tissues throughout the body and drained by lymphatic vessels past collections of B and T cells residing within secondary lymphoid structures.

Primary Lymphoid Organs

The anatomical structures where lymphocytes are generated and mature, consisting exclusively of the bone marrow (hematopoiesis and B-cell maturation) and the thymus (T-cell maturation).

Secondary Lymphatic Organs

Tissues and organs where mature, naive lymphocytes gather to encounter antigen, including lymph nodes, the spleen, tonsils, adenoids, Peyer's patches, and the appendix.

Peyer's Patches

Specialized secondary lymphoid aggregates located in the lining of the small intestine that sample mucosal contents and serve as major sites for intestinal immune surveillance.

M Cells

Specialized intestinal epithelial cells positioned over Peyer's patches that transport luminal antigens and microbes across the epithelial barrier to waiting macrophages, dendritic cells, and lymphocytes.

Antigen

Any molecule capable of binding specifically to an antibody, B-cell receptor (BCR), or T-cell receptor (TCR), though it does not necessarily elicit an immune response on its own.

Immunogen

A specific type of antigen that successfully provokes or stimulates an immune response in the host.

Epitope

A discrete, recognized portion of an antigen (often consisting of a stretch of $10\text{–}16\text{ amino acids}$ or a three-dimensional shape) bound by an antibody or lymphocyte receptor; also known as an antigenic determinant.

T-Dependent Antigens

Antigenic molecules that require peptide processing and confirmation by helper T ($\text{T}_\text{H}$) cells before B cells can proliferate and differentiate into antibody-producing plasma cells.

T-Independent Antigens

Antigens featuring repetitive identical subunits (such as bacterial polysaccharides or lipopolysaccharides) that can activate B cells without helper T cell participation.

Cluster of Differentiation (CD) Markers

Surface marker proteins used to classify lymphocytes, including CD4 on helper T cells, CD8 on cytotoxic T cells and macrophages, and CD19 on B cells.

Clonal Selection and Expansion

The proliferation of an individual antigen-specific naive B or T cell into a large clone of $10{,}000\text{–}50{,}000\text{ cells}$ upon receiving proper activation signals, causing localized lymph node swelling.

Antibody Structure (Fab and Fc Regions)

A quaternary Y-shaped protein consisting of two identical heavy chains and two identical light chains; the Fab arms contain the variable antigen-binding sites, while the Fc stem is constant and determines class function.

Class Switching

A biological process wherein activated B cells change the heavy-chain constant region of the antibodies they synthesize (shifting from initial IgM to IgG, IgA, or IgE) in response to T-helper cell cytokine signals.

Immunoglobulin M (IgM)

A pentameric antibody ($970{,}000\text{ daltons}$) making up $5\text{–}13\%$ of serum immunoglobulins; it is the first class produced in a primary response, effectively cross-links antigens, and triggers the classical complement pathway.

Immunoglobulin G (IgG)

The most abundant monomeric antibody in blood and tissues ($80\text{–}85\%$), possessing the longest half-life ($21\text{ days}$) and the unique ability to cross the placenta to provide passive fetal protection.

Immunoglobulin A (IgA)

The most abundantly synthesized immunoglobulin class in the body, secreted as a dimer ($390{,}000\text{ daltons}$) into mucosal secretions, saliva, tears, and breast milk to defend epithelial barriers.

Immunoglobulin D (IgD)

A monomeric immunoglobulin making up less than $1\%$ of serum antibody that is primarily involved in the development and maturation of the antibody response.

Immunoglobulin E (IgE)

A monomeric antibody present at very low levels ($<0.01\%$) that binds via its Fc region to receptors on mast cells and basophils, triggering granule release during allergic responses and parasite defense.

Protective Outcomes of Antibody-Antigen Binding

The functional clearance outcomes of antibody binding: neutralization, opsonization, complement system activation, immobilization and prevention of adherence, cross-linking, and antibody-dependent cellular cytotoxicity (ADCC).

Neutralization

A protective mechanism in which antibodies bind toxins or viral adhesion proteins, directly blocking them from attaching to and entering susceptible host cells.

Opsonization

The coating of foreign particles or bacteria by antibodies (or complement component C3b) that allows phagocytes to bind and engulf the target with high efficiency.

Antibody-Dependent Cellular Cytotoxicity (ADCC)

A cytotoxic defense mechanism in which Natural Killer (NK) cells bind the Fc stems of antibodies coating an infected or abnormal 'self' cell, triggering targeted apoptosis of the tagged cell.

MHC Class I vs. MHC Class II Molecules

MHC Class I is present on all nucleated cells and presents endogenous peptides to CD8 T cells, whereas MHC Class II is expressed on professional antigen-presenting cells to present exogenous peptides to CD4 T cells.

Human Leukocyte Antigens (HLA)

The human major histocompatibility complex (MHC) gene cluster comprising loci such as HLA-B, HLA-C, and HLA-A that exhibit extensive polymorphism and dictate graft rejection and self-tolerance.

Co-Stimulatory Molecules

Protective surface signals produced by dendritic cells only when presenting microbial or 'danger' antigens; required alongside TCR binding to activate naive T cells rather than inducing anergy.

Anergy

A state of permanent metabolic unresponsiveness induced when a naive lymphocyte recognizes an antigen in the absence of necessary co-stimulatory signals, leading to subsequent apoptosis.

Natural Killer (NK) Cells

Innate cytotoxic lymphoid cells that recognize and kill tumor or virally stressed 'self' cells that have downregulated MHC Class I molecules, inducing apoptosis via delivery of cytotoxic granules and tumor necrosis factor (TNF).